Literature DB >> 10749239

FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features.

K L Berger1, S A Nicholson, F Dehdashti, B A Siegel.   

Abstract

OBJECTIVE: Our goal was to assess the sensitivity of positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) for the detection of mucinous carcinoma and to determine the histologic features of these tumors that may affect lesion detectability.
MATERIALS AND METHODS: A retrospective review of all patients with mucinous carcinoma who had undergone FDG PET at our institution from 1995 through 1998 identified 25 patients with new or recurrent mucinous carcinoma at the time of PET. In 22 of these patients, tissue specimens available from either core biopsy or surgical resection allowed detailed histologic analysis.
RESULTS: FDG PET revealed mucinous carcinoma in only 13 (59%) of 22 patients, resulting in an unusually high percentage (41%) of false-negative results. Two histologic features were found to be predictive of FDG PET results: tumor cellularity (p = 0.011) and the amount of mucin within the tumor mass (p = 0.009). There was a positive correlation between tumor FDG uptake and cellularity but a negative correlation with the amount of mucin.
CONCLUSION: FDG PET is limited in the evaluation of mucinous tumors, particularly in hypocellular lesions with abundant mucin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10749239     DOI: 10.2214/ajr.174.4.1741005

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  71 in total

Review 1.  Hereditary diffuse gastric cancer: a family diagnosis and treatment.

Authors:  Adedayo A Onitilo; Govinda Aryal; Jessica M Engel
Journal:  Clin Med Res       Date:  2012-06-21

Review 2.  Malignancies with Low Fluorodeoxyglucose Uptake at PET/CT: Pitfalls and Prognostic Importance: Resident and Fellow Education Feature.

Authors:  Robert R Flavell; David M Naeger; Carina Mari Aparici; Randall A Hawkins; Miguel H Pampaloni; Spencer C Behr
Journal:  Radiographics       Date:  2016 Jan-Feb       Impact factor: 5.333

3.  Quantitative assessment of diffusion-weighted MR imaging in patients with primary rectal cancer: correlation with FDG-PET/CT.

Authors:  Jing Gu; Pek-Lan Khong; Silun Wang; Queenie Chan; Wailun Law; Jingbo Zhang
Journal:  Mol Imaging Biol       Date:  2010-09-25       Impact factor: 3.488

4.  Lobar mucinous bronchioloalveolar carcinoma of the lung showing negative FDG uptake on integrated PET/CT.

Authors:  Yon Mi Sung; Kyung Soo Lee; Byung-Tae Kim; Joungho Han; Eun Jeong Lee
Journal:  Eur Radiol       Date:  2005-02-17       Impact factor: 5.315

5.  Current and Future Imaging Paradigms in Colorectal Cancer.

Authors:  Umar Mahmood; Rabi Upadhyay
Journal:  Semin Colon Rectal Surg       Date:  2007-06

Review 6.  Surgical management of colorectal liver metastases: a European perspective.

Authors:  Declan Fj Dunne; Robert P Jones; Hassan Z Malik; Stephen W Fenwick; Graeme J Poston
Journal:  Hepat Oncol       Date:  2013-12-20

7.  FDG PET-CT SUVmax and IASLC/ATS/ERS histologic classification: a new profile of lung adenocarcinoma with prognostic value.

Authors:  Marina Suárez-Piñera; José Belda-Sanchis; Alvaro Taus; Albert Sánchez-Font; Antoni Mestre-Fusco; Marcel Jiménez; Lara Pijuan
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-04-25

8.  Polypoid endometriosis: a mimic of malignancy.

Authors:  Soleen Ghafoor; Yulia Lakhman; Kay J Park; Iva Petkovska
Journal:  Abdom Radiol (NY)       Date:  2020-06

Review 9.  Epidemiology and management options for colorectal cancer in children.

Authors:  Raya Saab; Wayne L Furman
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

10.  Recurrent pneumonia due to an appendiceal mucinous cystadenocarcinoma: a rare presentation of a rare malignancy.

Authors:  Karin G Gerritsen; Peter H Slee; Thomas L Bollen; Wim van Hecke; Cornelis A Seldenrijk; Ruth G Keijsers; Vincent A Duurkens
Journal:  Clin Med Oncol       Date:  2009-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.